Australia
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 7.56 B
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
2 |
USD 2.54 M
|
June 30, 2024 | USD 4.80 | 5.03% |
|
Australia |
|
3 |
USD 2.22 M
|
June 30, 2024 | USD 2.04 | -5.56% |
|
Australia |
|
4 |
USD 12.00 K
|
June 30, 2024 | USD 1.67 | 2.45% |
|
Australia |
|
5 |
USD -25.14 M
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
The Vaccines company in Australia with the highest Gross Profit is CSL Limited (ASX: CSL.AX) at USD 7.56 B.
The Vaccines company in Australia with the lowest Gross Profit is Immutep Limited (NasdaqGM: IMMP) at USD -25.14 M.
The top 10 Vaccines companies in Australia by Gross Profit are CSL Limited, Alterity Therapeutics Limited, Immuron Limited, Incannex Healthcare Limited and Immutep Limited.
The bottom 10 Vaccines companies in Australia by Gross Profit are Immutep Limited, Incannex Healthcare Limited, Immuron Limited, Alterity Therapeutics Limited and CSL Limited.